Ohtsuki S, Kamoi M, Watanabe Y, Suzuki H, Hori S, Terasaki T. Correlation of induction of ATP binding cassette transporter A5 (ABCA5) and ABCB1 mRNAs with differentiation state of
human colon tumor.
Case Western Reserve University School of Medicine Stress signaling inhibitors potentiate genotoxin - induced apoptosis in
a human colon tumor model
Not exact matches
Researchers have injected mice with
human breast, ovary,
colon, bladder, brain, liver and prostate
tumors, and their new drug has killed the
tumors every time.
So he implanted various
human tumors — including ovarian, breast,
colon, liver, and brain — into mice and then injected the animals with antibodies that disable CD47.
Oncologists William Hahn, Robert Weinberg, and colleagues at the Whitehead Institute for Biomedical Research in Cambridge, Massachusetts, mutated the gene for one part of the enzyme and inserted it into cultured
human cells from
colon, ovary, and breast
tumors.
One of those genes, K - Ras, which was discovered nearly 30 years ago, is mutated in 30 percent of
human tumors, including 90 percent of pancreatic cancers, 40 percent of
colon cancers, and 20 percent of non-small cell lung cancers.
For the animal study, the researchers separated 52 mice with
colon cancer
tumors into three groups, including a control group and groups that were fed either the grape compounds or sulindac, an anti-inflammatory drug, which was chosen because a previous study showed it significantly reduced the number of
tumors in
humans.
In
humans,
colon cancer often spreads to the liver and forms small
tumors that are difficult to detect, similar to ovarian
tumors.
«We were able to transplant these 3 - D mini-intestinal
tumors into the
colon of recipient mice and recapitulate many aspects of
human disease,» Yilmaz says.
Using the gene - editing system known as CRISPR, MIT researchers have shown in mice that they can generate
colon tumors that very closely resemble
human tumors.
Once formed, many of these experimental
tumors spread to the liver, just like
human colon cancers often do.
Almost 30 years ago, scientists discovered that
colon tumors in
humans usually acquire cancerous mutations in a particular order, but they haven't been able to accurately model this in mice until now.
Additionally, overexpression of POSTN in
human mammary epithelial and breast cancer cells resulted in enhanced
tumor growth and metastasis (Wang et al., 2013), which is similar to a
colon cancer cell model where overexpression of POSTN resulted in an increase in the number and size of liver metastases (Bao et al., 2004).
Further research uncovered a broad spectrum of cell surface stem cell markers (e.g., CD133, CD44, and CD24) that allow the identification of CSCs in
human solid
tumors, including brain, breast, prostate, pancreas, liver, ovary, skin,
colon cancers, and melanoma (3 - 6)(Figure 1 based on 7).
Acquired
tumor cell resistance to sunitinib causes resistance in a HT - 29
human colon cancer xenograft mouse model without affecting sunitinib biodistribution or the
tumor microvasculature
Using
human colon cancer cells and primary
human fibroblasts isolated from
tumors and adjacent normal tissues, Alexandros Glentis and colleagues at the Institut Curie addressed the question of whether the cancer cells or the CAF cells were responsible for the breakdown of the basement membrane that leads to cancer progression.
While cautioning that the new radiation delivery system is still far from ready for use in people, Abraham notes that P32 gives off high energy that can penetrate through 5 millimeters of
human tissue, making it a good candidate to tackle
colon cancer since
colon cancer cells can often form large, thick
tumors into which drugs may not penetrate very well.
The most frequent
tumors in
human — cancer of the
colon, breast, lung, and prostate — all involve mutations in
tumor suppressor genes.
Studies of Gluts in
human tumors have shown a significant increase in the abundance of Glut1 and Glut3 mRNA in cancers of the esophagus,
colon, and pancreas, overexpression of Glut1 and Glut3 mRNA and Glut1 protein expression in head and neck
tumors and Glut1 protein overexpression in breast and renal cell carcinomas
They help block the ability of cancer cells to produce the
tumor invasion enzyme in the first place, in both
human colon cancer cells, and
human breast cancer.
Phytates have been shown to inhibit the growth of
human leukemia cells,
colon cancer cells, both estrogen receptor - positive and negative breast cancer cells, voicebox cancer, cervical cancer, prostate cancer, liver
tumors, pancreatic, melanoma, and muscle cancers.
Worse, excessive butt - scooting can be a sign of
tumors (think benign
colon polyps in
humans) in your baby's anal glands and cavity.